We found this possible mechanism of CAP’s anti-obesity effect by measuring the expression of FFAR2, PYY, GLP1, PYY-Y2, GLP-1R, POMC, CART, NPY, and AgRP. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.